LncRNA SNHG6 Upregulates KPNA5 to Overcome Gemcitabine Resistance in Pancreatic Cancer via Sponging miR-944

• Prif Awduron: Ge Gao (Awdur), Xin Li (Awdur), Hui Wu (Awdur), Ling-li Huang (Awdur), Yu-xin Lin (Awdur), Zhi Huo (Awdur), Zhong-yuan Xiang (Awdur), Xiao Zhou (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: MDPI AG, 2023-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Gemcitabine (GEM) is the gold-standard therapeutic regimen for patients with pancreatic cancer (PC); however, patients may receive limited benefits due to the drug resistance of GEM. LncRNA SNHG6 is reported to play key roles in drug resistance, but its role and molecular mechanism in PC remain inco...